Literature DB >> 15467342

The impact of comorbidity on outcomes.

Jay F Piccirillo1, Irene Costas.   

Abstract

Patients often have other diseases, illnesses, or conditions in addition to the disease under study. These other medical conditions are referred to as comorbidity. Comorbidity can impact on diagnosis, prognosis, and selection of therapy. There are a variety of instruments available to measure the type and severity of comorbid ailments. Comorbidity information can be obtained from direct discussions with the patient, a review of the medical record, or from electronic databases that contain billing information. The method of comorbidity assessment can impact on the interpretation of results. Accurate comorbid information will improve the conduct of and generalizability of clinical trials, evaluation of outcomes from observational research, population-based epidemiological studies, and patient-physician communication.

Entities:  

Mesh:

Year:  2004        PMID: 15467342     DOI: 10.1159/000079875

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  9 in total

1.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

Authors:  Mohamed L Sorror; Sergio Giralt; Brenda M Sandmaier; Marcos De Lima; Munir Shahjahan; David G Maloney; H Joachim Deeg; Frederick R Appelbaum; Barry Storer; Rainer Storb
Journal:  Blood       Date:  2007-09-14       Impact factor: 22.113

2.  Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes.

Authors:  Naval Daver; Kiran Naqvi; Elias Jabbour; Tapan Kadia; Courtney DiNardo; Marylou Cardenas-Turanzas; Sherry Pierce; Khanh Thi-Thuy Nguyen; Carlos Bueso-Ramos; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Am J Hematol       Date:  2014-02-21       Impact factor: 10.047

3.  Did changes in drug reimbursement after the medicare modernization act affect chemotherapy prescribing?

Authors:  Mark C Hornbrook; Jennifer Malin; Jane C Weeks; Solomon B Makgoeng; Nancy L Keating; Arnold L Potosky
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

4.  Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.

Authors:  Katherine L Kahn; John L Adams; Jane C Weeks; Elizabeth A Chrischilles; Deborah Schrag; John Z Ayanian; Catarina I Kiefe; Patricia A Ganz; Nirmala Bhoopalam; Arnold L Potosky; David P Harrington; Robert H Fletcher
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

5.  Comparison of comorbidity collection methods.

Authors:  Dorina Kallogjeri; Sheila M Gaynor; Marilyn L Piccirillo; Raymond A Jean; Edward L Spitznagel; Jay F Piccirillo
Journal:  J Am Coll Surg       Date:  2014-03-19       Impact factor: 6.113

6.  Delta Shock Index During Emergency Department Stay Is Associated With in Hospital Mortality in Critically Ill Patients.

Authors:  Yi-Syun Huang; I-Min Chiu; Ming-Ta Tsai; Chun-Fu Lin; Chien-Fu Lin
Journal:  Front Med (Lausanne)       Date:  2021-04-22

7.  Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life.

Authors:  Stijn Keereweer; Jeroen D F Kerrebijn; Abrahim Al-Mamgani; Aniel Sewnaik; Robert J Baatenburg de Jong; Esther van Meerten
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-08       Impact factor: 2.503

8.  Comorbidity in adult bone sarcoma patients: a population-based cohort study.

Authors:  Ninna Aggerholm-Pedersen; Katja Maretty-Nielsen; Johnny Keller; Steen Baerentzen; Akmal Safwat
Journal:  Sarcoma       Date:  2014-02-27

9.  Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas.

Authors:  Herbert Ho-Fung Loong; Carlos King Ho Wong; Yihui Wei; Sampson Sui Chun Kwan; Yingjun Zhang; Teresa Tse; Yat-Ming Lau; Linda K S Leung; Gordon C H Tang
Journal:  ESMO Open       Date:  2020-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.